← Back to Search

Intervention Arm for Smoking Cessation

N/A

Waitlist Available

Led By Theodore C Friedman, M.D., Ph.D.

Research Sponsored by Friends Research Institute, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in carbon monoxide and cotinine levels from 6 months at 12 months

Awards & highlights

Study Summary

This trial will test a sustainable tobacco screening, treatment, and cessation program in primary care and mental health clinics in L.A. County, to see if it is effective and feasible.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in carbon monoxide and cotinine levels from 6 months at 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in carbon monoxide and cotinine levels from 6 months at 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in carbon monoxide and cotinine levels from 6 months at 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Smoking Cessation Rate

Trial Design

2Treatment groups

Active Control

Group I: Intervention ArmActive Control1 Intervention

Healthcare providers from clinics participating in the intervention refer existing clients to study coordinators for smoking cessation services, wherein the coordinators link clients to the smoking cessation services, which include: 1) a weekly cognitive-behavioral therapy smoking cessation (CBT) counseling group; and 2) smoking cessation medication, which include varenicline (Chantix), bupropion (Zyban) and nicotine patches, gum, and lozenges. Clients interested in these medications will meet with the prescribing clinician to help choose the best prescription option. In addition to linking clients to the smoking cessation services, coordinators will invite clients to participate in the outcome study. Existing clients can sign-up for these services and/or the outcome study directly with the study coordinators and do not require a healthcare provider referral.

Group II: Treatment As Usual ArmActive Control1 Intervention

Existing clients can be referred to the outcome study by their healthcare providers from clinics designated as TAU or they can sign-up directly with the study coordinators.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Friends Research Institute, Inc.Lead Sponsor

52 Previous Clinical Trials

20,202 Total Patients Enrolled

University of CaliforniaOTHER

42 Previous Clinical Trials

416,942 Total Patients Enrolled

Theodore C Friedman, M.D., Ph.D.Principal InvestigatorCharles R. Drew University of Medicine & Science

1 Previous Clinical Trials

20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are actively engaging in this medical experiment?

"Affirmative. The information hosted on clinicaltrials.gov reveals that this research is recruiting participants, having first been advertised on October 1st 2019 and recently updated in August 2021. A total of 1200 people are needed from one site to be evaluated for the trial's efficacy."

Answered by AI

Is this medical trial currently recruiting participants?

"Indeed, the information available on clinicaltrials.gov attests to this medical experiment's current recruitment status. Initially posted in October 2019 and edited last August 2021, the trial is searching for 1,200 participants from one site."

Answered by AI

Who else is applying?

What state do they live in?

California

What site did they apply to?

Los Angeles County Department of Health Services and Department of Mental Health Services

What portion of applicants met pre-screening criteria?

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

Because I need to stop smoking I just can’t seem to. I’m a smoker looking to stop and honestly curious about this study.

PatientReceived 1 prior treatment

I want to quit smoking for many reasons and have been struggling with it. I'd like to help support the community in finding help for smokers. Lastly, I'd like to make some money in the process.

PatientReceived 2+ prior treatments

What questions have other patients asked about this trial?

Are the screenings compensated ?? How long is the trial? Is it inpatient or outpatient? If outpatient, how many visits and how long would they be? What is the pay rate and what would the payday(s) be?

PatientReceived no prior treatments

Recent research and studies

TrialsJournal

Embedding Comprehensive Smoking Cessation Programs into Community Clinics: Study Protocol for a Cluster-randomized Controlled Trial

Baskerville, Wave-Ananda, Theodore C. Friedman, Brian Hurley, Susan Hsieh, Tasha Dixon, Norma Mtume, Martin L. Lee, Luz Rodriguez, Briana Lopez, and Lara A. Ray. 2022. “Embedding Comprehensive Smoking Cessation Programs into Community Clinics: Study Protocol for a Cluster-randomized Controlled Trial”. Trials. Springer Science and Business Media LLC. doi:10.1186/s13063-022-06023-3.

clinicaltrials.govStudy

Embedding Comprehensive Smoking Cessation Programs Into Community Clinics

2019. "Embedding Comprehensive Smoking Cessation Programs Into Community Clinics". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04717544.